Skip to main content

Glenmark's antiviral combination for moderate Covid-19 shows no clinical benefit

Glenmark Pharmaceuticals Ltd on Friday said addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients. Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment, the trial did not meet key end-points, the company said.

The trial's findings confirm that the addition of Umifenovir does not show any incremental benefit in clinical outcomes, Monika Tandon, senior vice president & head, Clinical Development, Global Specialty/Branded Portfolio at the company, said in a statement , adding that favipiravir alone remains the effective choice for mild to moderate COVID-19 infection.

Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014, while Umifenovir is licensed as a treatment for some types of flu infections in Russia and China.

Fujifilm last month said a late-stage study of Avigan showed it reduced recovery times for COVID-19 patients with non-severe symptoms.

Mumbai-based Glenmark in July said its version of Favipiravir alone showed promise in a late-stage study of patients with mild to moderate coronavirus infection.

This was the second clinical study after the successful Favipiravir monotherapy trial earlier this year that led the company to receiving the Emergency Use Authorisation for Favipiravir.

This second study titled the FAITH trial evaluated the possible superiority of the combination’s efficacy against Favipiravir monotherapy.

The FAITH study enrolled a total of 158 hospitalized patients with moderate COVID-19 in India.

In June 2020, Glenmark became the first company in India to receive manufacturing and marketing approval for FabiFlu as part of accelerated approval process, considering the emergency situation of the COVID-19 outbreak in the country.

Comments

Popular posts from this blog

Increased risks of drop out for women and girls : CoronaVirus Updates

The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.

Covid - 19 Effect : Increased risks of violence against women and girls, exploitation and child marriage

In addition to dropping out of school, education disruption puts girls and young women at increased risk of numerous abuses: child marriage, exploitation, child labor, early pregnancy, and gender-based violence.  School closures, the loss of protective spaces provided by school, lockdowns spent at home and COVID-19 mitigation measures disrupt children›s routine, and place new stressors on parents and caregivers, contributing to an increase in the severity and frequency of domestic violence across the country. School closures represent the loss of a safe space, where girls who are experiencing violence and abuse can find respite, and where there is an opportunity for adults to identify signs of abuse and intervene in their lives. School closures and the socio-economic impact of COVID-19 have increased the risk of reliance on negative coping mechanisms, such as child marriage. With many families losing their means of livelihood, girls are at increased risk of being forced to drop...